Income statement
USD
Annual
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 61M | 137M | 122M | 51M | 54M |
| Gross Profit | -14M | 36M | 13M | 6M | 2M |
| Operating Income | -42M | 19M | 634K | -6M | -10M |
| EBITDA | -41M | 20M | 2M | -5M | -5M |
| Net Income | -46M | 21M | -681K | -14M | -11M |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$0.42
-4.55% today
1Y Change
-84.44%
Window
Jun 20, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SurgePays, Inc. (SURG) is a Technology stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $0.42 and down 84.4% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -6.4%, EPS growth of +24.7%, a dividend yield of 0.0%. What stands out right now is revenue -6.4%, EPS +24.7%, free cash flow +2.4% with operating margin -59.9% and ROIC 1874.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SURG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SURG
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SURG Max Drawdown
-88.34%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SURG and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$54.4M
+6.6% YoY
FY Net Income
-$10.7M
+20.8% YoY
Free Cash Flow
-$4.3M
+71.8% YoY
Revenue Growth
-6.4%
EPS Growth
+24.7%
Gross Margin
-18.6%
Net Margin
-63.3%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 61M | 137M | 122M | 51M | 54M |
| Gross Profit | -14M | 36M | 13M | 6M | 2M |
| Operating Income | -42M | 19M | 634K | -6M | -10M |
| EBITDA | -41M | 20M | 2M | -5M | -5M |
| Net Income | -46M | 21M | -681K | -14M | -11M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 12M | 15M | 7M | 6M | 674K |
| Total Assets | 24M | 42M | 34M | 20M | 7M |
| Total Liabilities | 9M | 14M | 29M | 16M | 18M |
| Shareholder Equity | 15M | 28M | 5M | 4M | -11M |
| Total Debt | 5M | 5M | 8M | 8M | 8M |
| Net Debt | -7M | -9M | 1M | 1M | 7M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
4M
+71.7% YoY
Capital Expenditures
7K
+87.2% YoY
Free Cash Flow
4M
+71.8% YoY
Key ratios
Gross Margin
-18.6%
Operating Margin
-59.9%
Net Margin
-63.3%
ROE
1044.0%
Debt / Equity
-0.88x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.